Second Survey of Intensive Care in India (INDICAPS-II)

Indian Society of Critical Care Medicine

Status: Completed

Conditions: Critical Illness

Treatments: Other: Observation

Study type: Observational

Funder types: Other

Identifiers

NCT03631927

INDICAPS2

Details and patient eligibility

About

INDICAPS was the first large scale, multicentre survey launched by the ISCCM. The aim was to gather information about ICUs, organizational characteristics, patient casemix, the types and severity of illness, monitoring and therapeutic modalities used, types of infections, and other such data. This was performed between July 2010 and April 2011 and published in 2016.[1] Over the last 8 years, there has been a significant difference in the delivery of intensive care services, critical care education, socioeconomic indicators, antibiotic resistance patterns and other aspects of practices in Indian ICUs. It is therefore necessary to revisit and resurvey the current trends in intensive care practices in India, and to reflect the vast spectrum of critical care illness, services and practices.

Similar to INDICAPS, which was a point-prevalence study of all patients present in the ICU on four different days over a one-year period, INDICAPS II will record data of all patients admitted to the ICU on 4 different days.

Full description

INDICAPS II will record data of all patients admitted to the ICU on 4 different days (August 23, 2018; October 25, 2018; December 13, 2018; April 11, 2019) in a cross-sectional design. Data collection includes:

1. On admission: demographic characteristics, comorbidities, source of admission, primary and secondary admission diagnoses,
2. Baseline data (on the study day), including parameters used to calculate SAPS II score and SOFA score and infections,
3. Information on monitoring modalities, mechanical ventilation, nutrition, fluid therapy, other routine ICU practices

c. Outcome at ICU and hospital discharge d. Organisation of ICU services

Enrollment: 5,094 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients present in the ICU on August 23, 2018; October 25, 2018; December 13, 2018; April 11, 2019

Exclusion criteria

• None

Trial design

5,094 participants in 1 patient group

Patient

Description:

Patients admitted to participating ICUs on the specified dates

Treatment:

Other: Observation